Tafetinib

· Nanjing Yoko Biomedical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tafetinib, covering 2016-03-24 to 2016-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Tafetinib in Chinese Patients With Advanced Solid Tumor [Phase 1]